ID   BC44
AC   CVCL_D724
DR   Cosmic; 1696918
DR   Wikidata; Q54795279
RX   PubMed=22669776;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22669776).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
RX   PubMed=22669776; DOI=10.1007/s13402-012-0082-8;
RA   Koch A., Hatina J., Rieder H., Seifert H.-H., Huckenbeck W.,
RA   Jankowiak F., Florl A.R., Stoehr R., Schulz W.A.;
RT   "Discovery of TP53 splice variants in two novel papillary urothelial
RT   cancer cell lines.";
RL   Cell. Oncol. (Dordr.) 35:243-257(2012).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//